A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Investigational Treatment Gaining Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a robust market exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid British shipping. Vendors promote the substance there before directing buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.
Several professionals said the popularity for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.
Some influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.
Service Response and Material Elimination
Based on the social media company, the platform has removed problematic material and banned associated hashtags and query recommendations. The company stated it was dedicated to keeping the platform secure and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Research also found groups with up to nine thousand participants selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, filled with photos of slimming results, glowing reviews and step-by-step guides for mixing or administering at residence.
Within minutes of joining one community, a seller shared contact information, where most purchases occur. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.
Product Information and Pricing
Within these communities, messages display black plastic packages with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When asked how long a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for the messaging service stated it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they cannot confirm. Although the research behind this drug is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.
Her team has previously seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to potentially significant health risks”.
